INmune Bio: CORDStrom Is A Game-Changer, As Investors Await Alzheimer's Results
INmune Bio's high-upside potential with CORDStrom for RDEB and XPro for Alzheimer's, offering up to 144.8x returns. Click ...
The Clinton Herald17 小时
TO YOUR GOOD HEALTH: Over-the-counter treatments don't help man's enlarged prostate
I am 71, and I recently saw my urologist for urinating a lot and not getting enough sleep. He performed a flow test and a scope, then ...
The North West Star10 小时
Australia's economy 'held hostage' by US tariffs
Further tariffs on Australian goods have clouded the nation's economic outlook and could put more businesses at ...